Several previous genomic studies have reported that gene fusions and splice alterations are recurrent mechanisms leading to inactivation of NF2 and BAP1 in MM, and the present study provided additional data interpretation to the results in these previous studies [16, 45]. The gene discussed is BAP1; the disease is Miyoshi myopathy.